Related Experiment Videos
[Converting enzyme inhibitors in diabetes]
1Service médecine B, CHU, Angers.
La Revue Du Praticien
|December 15, 1992
Summary
Angiotensin-converting enzyme (ACE) inhibitors are widely used for hypertensive diabetics due to their efficacy and safety. They may protect kidney function in diabetic microangiopathy, independent of blood pressure reduction.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Endocrinology
Context:
- Hypertension and diabetes frequently coexist and worsen outcomes.
- ACE inhibitors are a common treatment for hypertensive individuals with diabetes.
- The benefits of ACE inhibitors in this population are well-established, particularly regarding tolerance and efficacy.
Purpose:
- To evaluate the specific advantages of ACE inhibitors in hypertensive diabetics.
- To assess their impact on insulin sensitivity and kidney function.
- To understand if renal protection is linked to their blood pressure-lowering effects.
Summary:
- ACE inhibitors demonstrate good tolerance and efficacy in hypertensive diabetics.
- They do not consistently improve insulin sensitivity.
- ACE inhibitors offer significant kidney protection against diabetic microangiopathy, likely through mechanisms beyond their antihypertensive action.
Impact:
- ACE inhibitors are crucial for managing hypertensive diabetics.
- They provide renal protection, mitigating diabetic nephropathy.
- Understanding their mechanism of action can optimize treatment strategies for kidney health.